AccessTicket vs Glucovibes
AccessTicket
Primavera Sound, S.L.
App Store
$0/mo
~$0/yr · 1K installs
VS
Glucovibes
xugarhero (XH Digital Health SL)
Google Play
$513/mo
~$6.2K/yr · 7K installs
Revenue winner
Glucovibes wins
+51300% vs other
Installs winner
Glucovibes wins
+600% vs other
MAU winner
Glucovibes wins
+548% vs other
Rating winner
AccessTicket wins
+500% vs other
Why Glucovibes is winning
Top 3 reasons - backed by the public App Store / Play Store numbers.
- Glucovibes earns roughly 513× more per month than AccessTicket - $513 vs $0.
- Subscription model. Glucovibes runs a $48.35/mo subscription that compounds; AccessTicket relies on one-shot IAP or ads.
- Bigger install base. Glucovibes has ~7K lifetime installs vs AccessTicket's ~1K - 7.0× the funnel top.
→ Find more apps with this revenue gap · Full Glucovibes report
Side-by-side metrics
Bars scale to whichever app is bigger on that row. Green = winner.
vs
Monthly revenue (est.)?
$0
▶
$513
Annual revenue (est.)
$0
▶
$6.2K
Lifetime installs (est.)
1K
▶
7K
Monthly active users (est.)?
121
▶
784.336
App Store rating
5.00★
◀
-
Total ratings
20
◀
0
US grossing rank
-
=
-
Cheapest monthly sub
No sub
▶
$48.35
IAP tiers detected
0 tiers
=
0 tiers
- Category
- Lifestyle
- Price
- Free
- Released
- Sep 1, 2021
- Last updated
- Apr 30, 2026
- File size
- 101.0 MB
- Content rating
- 4+
- Version
- 3.1.27
- Languages
- English
- Category
- Lifestyle
- Price
- Free
- Released
- Jan 31, 2023
- Last updated
- Mar 31, 2026
- File size
- -
- Content rating
- Everyone
- Version
- 2.8.1_2026_03_31
- Languages
- -
AccessTicket trajectory
Glucovibes trajectory
FAQ
Which makes more money, AccessTicket or Glucovibes? v
Glucovibes earns about $513 per month, while AccessTicket earns about $0. That is a ∞× revenue gap (~$513 more per month for Glucovibes). Annual revenue: AccessTicket ≈ $0/year, Glucovibes ≈ $6.2K/year. Estimates are derived from public App Store / Google Play signals - grossing rank, scraped IAP tiers, ratings and category benchmarks.
Which has more downloads, AccessTicket or Glucovibes? v
Glucovibes leads with about 7K estimated downloads vs 1K for AccessTicket - a 7.0× gap. AccessTicket's App Store downloads are estimated from 17 ratings × the standard 1:75 ratio. Glucovibes reports 5,000+ installs on Google Play.
Are AccessTicket and Glucovibes in the same App Store category on each store and competing for the same money? v
Yes - both apps sit in the Lifestyle category, which means they compete directly for the same paying users and category-level wallet share. Direct competitors, head-to-head.
What in-app purchases and subscription pricing do AccessTicket and Glucovibes offer? v
AccessTicket: no IAP detected on the public listing. Glucovibes: IAP range $11.99 - $194.99 per item. AccessTicket runs a "No App Store revenue (monetizes off-store)" monetization model; Glucovibes runs "Subscription (~$48.35/mo)". Scraped tier prices and detected subscription pricing drive the bulk of the per-app revenue estimate above.
Which has better ratings, AccessTicket or Glucovibes? v
AccessTicket edges ahead with a higher overall score (gap of 5.0 stars). Rating volume: AccessTicket 17 ratings, Glucovibes 0 ratings. Higher rating volume = stronger ASO signal even when star averages are close.
How accurate are these AccessTicket vs Glucovibes revenue estimates? v
Directional - typically within 2-3× of actual money earned for popular apps. The $0 for AccessTicket and $513 for Glucovibes are derived from App Store grossing rank / Google Play install ranges, scraped IAP tiers, ratings volume and category benchmarks (Lifestyle) - net of the 15-30% Apple/Google store cut. Real revenue depends on country mix, retention, refunds and ad fill rate, none of which Apple or Google publish.
How do I compare AccessTicket or Glucovibes to a different App Store app? v
Use the search box at the bottom of this page or paste any two App Store or Google Play links into the homepage tool. We auto-generate a permanent comparison URL with revenue, downloads, IAP tiers, subscription pricing and grossing rank for both apps.
